53 records – page 2 of 3.

Bill C-45: The Cannabis Act

https://policybase.cma.ca/link/policy13723
Date
2017-08-18
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA response to patented medicines regulations consultations

https://policybase.cma.ca/link/policy13690
Date
2017-06-28
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Canada’s lower-risk cannabis use guidelines (LRCUG)

https://policybase.cma.ca/link/policy13726
Date
2017-05-26
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts

https://policybase.cma.ca/link/policy13641
Date
2017-04-07
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

CMA submission to the study of Bill C-37

https://policybase.cma.ca/link/policy13617
Date
2017-04-06
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Consultation on the renewal of Federal Tobacco Control Strategy

https://policybase.cma.ca/link/policy13804
Date
2017-04-05
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Position statement on prescription drug shortages in Canada

https://policybase.cma.ca/link/policy10756
Last Reviewed
2017-03-04
Date
2013-05-25
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Policy Type
Policy document
Last Reviewed
2017-03-04
Date
2013-05-25
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Documents
Less detail

Regulation of Self-Care Products in Canada

https://policybase.cma.ca/link/policy13802
Date
2016-10-31
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Health care and patient safety

Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada

https://policybase.cma.ca/link/policy13936
Date
2016-10-18
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Population health, health equity, public health
Health care and patient safety

Legalization, regulation and restriction of access to marijuana

https://policybase.cma.ca/link/policy11954
Date
2016-08-29
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Health Canada’s Consultation on “Plain and Standardized Packaging”

https://policybase.cma.ca/link/policy13817
Date
2016-08-12
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

National pharmacare in Canada: Getting there from here

https://policybase.cma.ca/link/policy11959
Date
2016-06-01
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Consultation on the prescription drug list: Naloxone

https://policybase.cma.ca/link/policy11847
Date
2016-03-19
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.

https://policybase.cma.ca/link/policy11814
Date
2016-01-20
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Health care and patient safety

CMA's Response to Health Canada's Public Consultation Guide to New Authorities in reference to Bill C-17, Protecting Canadians from Unsafe Drugs Act (Vanessa's Law)

https://policybase.cma.ca/link/policy11599
Date
2015-06-08
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Complementary and alternative medicine (update 2015)

https://policybase.cma.ca/link/policy11529
Date
2015-05-30
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs
Policy Type
Policy document
Date
2015-05-30
Replaces
Complementary and alternative medicine (Update 2008)
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs
Documents
Less detail

Harms associated with opioids and other psychoactive prescription drugs

https://policybase.cma.ca/link/policy11535
Date
2015-05-30
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)

https://policybase.cma.ca/link/policy11519
Date
2015-05-14
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)

https://policybase.cma.ca/link/policy11297
Date
2014-10-28
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Tamper Resistance under the Controlled Drugs and Substances Act

https://policybase.cma.ca/link/policy11295
Date
2014-08-26
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

53 records – page 2 of 3.